Information on tumor mutational status was limited before the development of NGS because traditional Sanger sequencing and ...
Morphological profiling allows accurate identification of cell types in dense iPSC-derived cultures, allowing its use for quality control and differentiation monitoring.
With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to ...
Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. See why I ...
BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced that the BD Onclaritytm HPV ...
Before markets open, start your day smart. Get essential news and analysis with CNN Business' daily newsletter.
Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.
Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...
Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced its planned design of the ALPHA-ORBIT Phase ...
Personalized Medicine : By combining iPSCs with genome-editing technologies like CRISPR, scientists can introduce precise genetic modifications, such as knock-outs, knock-ins, or single base changes, ...